Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Sanofi expands research deal with gene editing startup Scribe
BioPharma Dive
Tue, 07/18/23 - 10:28 am
Tags:
Sanofi, gene editing, Scribe Therapeutics
FDA Approves Sanofi and AstraZeneca’s RSV Antibody for Newborns, Infants
BioSpace
Mon, 07/17/23 - 07:00 pm
Tags:
Sanofi, AstraZeneca, Beyfortus, nirsevimab, RSV, infants, pediatric, FDA
Dupixent goes back-to-back as top Rx, OTC pharma brand in June
Medical Marketing and Media
Thu, 07/6/23 - 10:16 am
Tags:
Dupixent, Sanofi, Regeneron
Sanofi blocks Sandoz's Jevtana generic in patent win
Fierce Pharma
Fri, 06/30/23 - 10:16 am
Tags:
Sanofi, Jevtana, generics, Sandoz, prostate cancer, legal
Sanofi outlines five-pronged approach to reel in €10B in vaccine sales by 2030
Fierce Pharma
Thu, 06/29/23 - 11:09 pm
Tags:
Sanofi, vaccines, R&D
Sanofi says it's back to the drawing board on mRNA flu vaccines
Reuters
Thu, 06/29/23 - 11:22 am
Tags:
Sanofi, vaccines, MRNA, flu vaccines, Flu
10 clinical trials to watch in the second half of 2023
BioPharma Dive
Wed, 06/28/23 - 11:44 am
Tags:
FDA, clinical trials, Sarepta Therapeutics, Bridge Bio, Sanofi, Merck KGaA, Pfizer, Novo Nordisk, Verve Therapeutics, Roche, Vertex Pharmaceuticals, JNJ, Bristol Myers Squibb, ATTR-CM, Elevidys, tolebrutinib, evobrutinib, danuglipron, tiragolumab, VX-548, lazertinib
Sanofi's $1.1B eczema drug hits midphase goal, spurring talk of phase 3 and new indications
Fierce Biotech
Tue, 06/27/23 - 10:09 am
Tags:
Sanofi, clinical trials, eczema, Kymab, amlitelimab
5 FDA decisions to watch in the third quarter
BioPharma Dive
Mon, 06/26/23 - 10:04 am
Tags:
FDA, SAGE Therapeutics, Biogen, zuranolone, Eisai, Leqembi, Sanofi, AstraZeneca, nirsevimab, Iveric Bio, Zimura, Alnylam, Onpattro
Alphabet's quantum spinoff starts working with AstraZeneca, Sanofi to accelerate R&D
Fierce Biotech
Fri, 06/23/23 - 10:01 am
Tags:
Alphabet, SandboxAQ, AstraZeneca, Sanofi, R&D, funding, molecular simulation, artificial intelligence
Aslan sells Japanese rights to would-be Dupixent rival for $12M
Fierce Biotech
Thu, 06/22/23 - 10:41 pm
Tags:
Aslan, Dupixent, Japan, eczema, Sanofi, Regeneron, eblasakimab
Sanofi says arbitration court rejects Boehringer's Zantac claims
Reuters
Wed, 06/21/23 - 10:53 am
Tags:
Sanofi, Boehringer Ingelheim, Zantac, legal
4 ways Sanofi is using AI to power pharma innovations
Beckers Hospital Review
Tue, 06/13/23 - 10:59 pm
Tags:
Sanofi, artificial intelligence, innovation
Biotech M&A is picking back up - here are the latest deals
BioPharma Dive
Tue, 06/13/23 - 11:37 am
Tags:
Novartis, Chinook Therapeutics, Paratek, Sobi, CTI BioPharma, Astellas, Iveric Bio, Assertio Holdings, Spectrum Pharmaceuticals, Merck, Prometheus Biosciences, Pfizer, Seagen, Sanofi, Provention Bio, Sun Pharma, Concert Pharmaceuticals, BioNTech, InstaDeep, AstraXeneca, CinCor Pharma, Ipsen, Albireo, Chiesi, Amryt, Moderna Therapeutics, OriCiro Genomics
Medicare sets next tranche of drugs to face price hike penalties
BioPharma Dive
Sun, 06/11/23 - 11:02 pm
Tags:
Medicare, Inflation Reduction Act, drug pricing, Amgen, Sanofi, Seagen
FDA sets the stage for adcomm on Sanofi, AZ's RSV prospect later this week
Fierce Pharma
Wed, 06/7/23 - 09:42 pm
Tags:
Sanofi, AstraZeneca, GSK, Pfizer, RSV, vaccines, FDA
Dupixent reclaims throne as top Rx, OTC pharma brand in May
Medical Marketing and Media
Tue, 06/6/23 - 11:13 am
Tags:
Dupixent, Sanofi, Regeneron, DTC advertising
Sanofi sees midphase success in multiple sclerosis decades after safety concerns scuttled peers
Fierce Biotech
Wed, 05/31/23 - 10:54 am
Tags:
Sanofi, MS, multiple sclerosis, clinical trials, frexalimab
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
Tags:
FDA, Albireo Pharma, Aldeyra Therapeutics, Alvotech, Amneal Pharmaceuticals, Argenx, ARS Pharmaceuticals, AstraZeneca, Bayer, Bio-Thera Solutions, Biogen, BioMarin Pharmaceutical, Bristol Myers Squibb, Eisai, Eton Pharmaceuticals, F2G, Fabre-Kramer Pharmaceuticals, Fresenius, GSK, Intercept Pharmaceuticals, Ipsen, Ironwood Pharmaceuticals, Merck, Novaliq, Pfizer, Regeneron, Roche, Sanofi, Sarepta Therapeutics, Shionogi, Swedish Orphan Biovitrum, Takeda, Teva Pharmaceutica, UCB Pharma
Sanofi, Regeneron flesh out COPD data with Dupixent
Pharmaphorum
Mon, 05/22/23 - 10:16 am
Tags:
Sanofi, Regeneron, COPD, Dupixent

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.